NOVEL APPROACH FOR ISOLATION OF LYTIC BACTERIOPHAGES AGAINST STAPHYLOCOCCUS AUREUS Текст научной статьи по специальности «Фундаментальная медицина»

_ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ_

03.02.03 - Микробиология (медицинские науки)

УДК 578.5:579.61

DOI 10.17021/2020.15.4.8.15

© E.O. Rubalskii, O.A. Bashkina, A. Haverich, A.V. Aleshkin, M.A. Samotrueva, E.A. Popov, C. Kuehn, R.O. Abdrakhmanova, E.G. Dosmukhanova, S. Ruemke, C. Salmukas, M.O. Rubalsky, 2020

NOVEL APPROACH FOR ISOLATION OF LYTIC BACTERIOPHAGES AGAINST

STAPHYLOCOCCUS AUREUS

Rubalskii Evgenii O., Cand. Sci. (Biol.), Resident, Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 1 Carl-Neuberg-Straße, Hannover, 30625, Germany; Leading Research Associate, Laboratory of Applied Immunochemistry, G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 10 Admiral Makarov St., Moscow, 125212, Russia; tel.: +7-965-447-90-84, e-mail: [email protected], [email protected].

Bashkina Ol'ga A., Dr. Sci. (Med.), Professor, Head of Department, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: 8-927-570-99-31, e-mail: [email protected].

Haverich Axel, Dr. Med., Professor, Director of Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 1 Carl-Neuberg-Straße, Hannover, 30625, Germany, tel.: +49-511-532-6580, e-mail: [email protected].

Aleshkin Andrey V., Dr. Sci. (Biol.), Head of Laboratory of Clinical Microbiology and Biotechnology of Bacteriophages, G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 10 Admiral Makarov St., Moscow, 125212, Russia, tel.: (495) 452-18-16, e-mail: [email protected].

Samotrueva Marina A., Dr. Sci. (Med.), Head of Department, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: (8512) 52-36-58, e-mail: [email protected].

Popov Evgeniy A., Dr. Sci. (Med.), Professor, Head of Department, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: (8512) 52-41-43, e-mail: [email protected].

Kuehn Christian, Dr. Med., Professor, Cardiothoracic and Transplant Surgeon, Consultant, Leading Surgeon of Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 1 Carl-Neuberg-Straße, Hannover, 30625, Germany, tel.: +49-511-532-6590, e-mail: [email protected].

Abdrakhmanova Radmila O., Assistant, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: (8512) 52-35-99, e-mail: [email protected].

Dosmukhanova Elmira G., Assistant, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: (8512) 52-35-99, e-mail [email protected].

Ruemke Stefan, Dr. med., MD, Resident, Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 1 Carl-Neuberg-Straße, Hannover, 30625, Germany, tel.: +49-511-532-2151, e-mail: [email protected].

Salmoukas Christina, Dr. med., MD, Resident, Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 1 Carl-Neuberg-Straße, Hannover, 30625, Germany, tel.: +49-511-532-2151, e-mail: [email protected].

Rubalsky Maxim O., Employee, City Diagnostic Laboratory, LLC, 27 3-ya Tikhvinskaya St., Astrakhan, 414004, Russia, tel.: +7 (8512) 70-55-70, e-mail: [email protected].

Strictly lytic or virulent bacteriophages against Staphylococcus aureus belong to order Caudovirales and comprise predominantly two genera: Kayvirus and Rosenblumvirus. Representatives of both taxonomic groups are well known as safe and viable antibacterial agents. Phages of the genus Kayvirus show usually a broad host range activity against clinical isolates of S. aureus. Nevertheless continuous isolation of new phages against these bacteria is required in order to provide sufficient activity for therapy of biofilms or to prevent phage inactivation by neutralizing antibodies. In the present study, we describe an approach for isolation of lytic bacteriophages of the genus Kayvirus by mitomycin C induction of clinical isolates of S. aureus. Our findings suggest the clinical isolates of S. aureus a reach source for lytic bacteriophages. However taking into account the inducibility of the Kayvirus representatives it have to be evaluated a presence of further unknown life cycles for these bacteriophages such as pseudolysogeny.

Key words: bacteriophage isolation, mitomycin C, Staphylococcus aureus, Kayvirus, lytic bacteriophages, pseudolysogenic bacteriophages.

Introduction. Increasing antibiotic resistance is a major global issue, especially in medicine. The emergence and spread of antibiotic resistance leads to the appearance of multi-resistant and even pan-resistant bacteria. In February 2017, the World Health Organization (WHO) published a list of 12 bacteria for which new antibacterial agents are urgently needed. Methicillin- and vancomycin-resistant Staphylococcus aureus are in fifth place on this list. The frequency of detection of staphylococci with multiple antibiotic resistance currently reaches 40-57 % [22], especially in nosocomial infections.

The efficacy of antibiotic therapy for nosocomial infections caused by S. aureus can be reduced or completely eliminated by the bacterial biofilm. Bacteria in biofilms are incorporated into their own exopoly-saccharides (EPS), which protect them from the penetration of antibiotics and significantly increase the mechanical stability of the biofilm. Such tolerance to antibiotics can be observed in the absence of their genetically determined antibiotic resistance. Therefore, bacteria in biofilms can often be tolerant to antibiotics, despite the antibiotic sensitivity of their planktonic forms [14, 21].

The use of virulent bacteriophages is an alternative to antibiotic therapy in the presence of a healthcare associated infection (HAI) and an infection caused by bacteria resistant to conventional antimicrobial drugs [3]. Bacteriophages (phages) are viruses that infect only bacteria with host specificity and growth inhibition activity for replication and reproduction. Virulent phage undergoes only a lytic cycle for host lysis and thus has the potential to develop as a new biocontrol agent against a specific host pathogen [4]. In addition, the phage takes advantage of the infection and lysis of antibiotic-resistant strains without affecting other bacteria or human cells.

However, in the case of infections associated with biofilms, phage therapy can last more than 8 weeks [2]. In addition, long-term or repeated courses of phage therapy may be ineffective due to the appearance in patients of neutralizing antibodies against the used bacteriophage strains [6].

In addition, the population of bacterial cells in the biofilm contains a small population of dormant cells - persistent bacteria, whose metabolism is significantly reduced. Therefore, they are more resistant to antimicrobial agents, including antibiotics, preventing the complete destruction of the biofilm even after prolonged high-dose antibiotic therapy. In these cases, the use of passive phage therapy is especially promising, which consists in achieving a sufficiently high number of bacteriophages adsorbed on bacterial cells, causing their so-called lysis from without due to penetration and subsequent depolarization of the persister cell membrane [1]. This dictates the need for a sufficiently active destruction of the biofilm matrix, which is necessary to increase the concentration of phages in the environment surrounding the bacteria.

Therefore, isolation of bacteriophages that most actively destroy mature biofilms of S. aureus is promising for increasing the efficiency and shortening the time of phage-mediated eradication of S. aureus biofilms. At the same time, the selection of virulent bacteriophages that are lytically active even against ly-sogenic isolates of this type of staphylococcus, which are more resistant to phage therapy, is relevant [7].

More than 90 % of clinical isolates of S. aureus carry one or more temperate phages in the form of prophages in their genome [15].

Lytic phages kill their bacterial host cell through lysis, while mild bacteriophages (or lysogenic phages) either integrate into the bacterial genome (forming a so-called prophage). In the case of environmental stress, functional prophages can be excised and enter the lytic cycle [16]. Another form of phage-bacteria coexistence is known as a pseudolysogeny when for example phage DNA exist as a plasmid in the bacterial cytoplasm. The phages of the genus Rosenblumvirus are known to coexist in equilibrium with their host staphylococci [9].

The presence of prophages in the bacterial genome acts as an additional gene pool of horizontally transferred genes, which makes bacteria more adaptable, for example, due to the presence of virulence genes, antimicrobial resistance genes, or survival factors [5, 12, 19].

Prophages without defects are able to be induced when exposed to factors damaging the host's DNA, when the so-called SOS response occurs, which confirms the lysogenicity of the host microorganism culture. One of the most widely used inducers of moderate bacteriophages is mitomycin C.

A potentially effective approach to the search for virulent (strictly lytic) S. aureus bacteriophages is their isolation from mature biofilms of S. aureus strains formed under in vitro conditions, isolated from the most typical biotopes of the human body for this pathogen and causing a chronic recurrent inflammatory process at the sites of their colonization. For example the most common infectious disease caused by S. aureus is recurrent tonsillitis. Its etiological significance is associated with its resistance to antimicrobial drugs and the ability to form biofilm in the tissues of the tonsils [8].

The aim of the study was to isolate strains of virulent staphylococcal bacteriophages from the micro-biota of the tonsils of patients with chronic tonsillitis, possessing lysing activity against circulating antibiotic-resistant S. aureus isolates forming mature biofilms.

Materials and methods. The studies were carried out on 106 surgically removed tonsils in patients with chronic adenoiditis or chronic tonsillitis (recurrent tonsillitis) at the Astrakhan branch of the Scientific and Clinical Center of Otorhinolaryngology of the Federal Medico-Biological Agency of the Russian Federation.

Sectional material was delivered to the laboratory within two hours after the planned tonsillectomy. The tonsil tissues were homogenized by grinding in a sterile porcelain mortar with the addition of sterile sand and saline. The homogenized product of each sample was spitted in two parts. The first part was plated on yolk-salt agar according to the Drygalski method with a sterile spatula to obtain isolated colonies. The inoculations were incubated at 37°C for 20-24 hours. After 20-24 hours, suspicious colonies with a golden yellow color and surrounded by a halo of lecithinase activity were subcultured onto nutrient agar slant in order to isolate a pure culture. Crops were incubated for 20-24 hours at 36-37°С. The isolates were identified using standard gram-microscopy, cultural methods and specific PCR. Isolates showing coccal morphology, gram-positive staining, beta-hemolysis and producing catalase, coagulase and DNase were tested for biofilm formation.

The biofilm biomass was measured using a standard technique for staining with crystal violet according to the method described by Stepanovic S. et al. [20].

LB broth was used as a nutrient medium. For the formation of biofilms, overnight broth cultures were used, brought with fresh LB broth to optical density (OD) ~ 0.2. The measurements were carried out in 96-well flat-bottomed plates in a volume of 200 ц1 at a wavelength of 595 nm on an iMark plate photometer (Bio-Rad, USA). Cultures standardized by OD were inoculated in a volume of 200 ц1 into the studied micro-titer plates, followed by incubations at 36-37°C for 20-24 hours, and titrated to determine the amount of CFU of introduced planktonic broth culture.

To check for the presence of inducible prophages, fresh daily cultures from solid media were transferred in a loop into 5 ml of LB broth and incubated for 2-2.5 hours at +36-37°C to reach the log phase. A solution of mitomycin C was prepared by adding sterile 10 ml of water for injection to a vial with powder for every 10 mg of the drug. The solution was sterilely poured into cryovials (100 ц1) and stored at -20°C (after thawing, it was stored at +4 С for up to 1 month). The preincubated suspension was added in an amount of 1-10 ^g of the prepared solution of mitomycin C to achieve a final concentration of 1 ^g/ml and incubated for 2-2.5 hours at + 37°C with periodic shaking. The cultures were inactivated with chloroform in a volume of 0.5-0.6 ml and the supernatant was obtained by centrifugation at 4000-5000 rpm for 20-30 minutes. The supernatant was collected in sterile tubes with vented stoppers and incubated at room temperature for 1-2 hours. Supernatants in undiluted form and in dilutions 10"2, 10"8 were tested for the presence of phages by the Gratia double agar layer plaque assay on the culture of S. aureus 2072 strain, free from induc-ible bacteriophages [13].

The second part of the homogenized tissue was suspended in 5 ml of saline, incubated for 2-2.5 hours at room temperature followed by the chloroform inactivation and centrifugation at 4000-5000 rpm for 20-30 minutes. The resulting supernatant was tested for a phage presence by the plaque assay on the culture of S. aureus 2072 strain.

For the plaque assay in both types of samples the LB medium with 1.5% agar-agar was poured into Petri dishes with a diameter of 90-100 mm in a volume of 20-30 ml (first layer). After solidification of the medium, the dishes were incubated in a thermostat at +36-37°C for 1.5-24 h to remove excess moisture. In a test tube with 2.5 ml of LB medium melted in a microwave oven and cooled to +45-49°C with an agar-agar content of 0.7% were added 1 ml of the test phage-containing sample and 0.2 ml of an overnight broth culture of S. aureus 2072 strain. The contents of the tubes were quickly mixed so as not to solidify the agar, and poured onto the surface of the first agar layer evenly in a second layer. After the agar had solidified, the inoculation was incubated in a thermostat at the temperature optimal for the host strain. The result was taken into account after 18-24 hours. The presence of a bacteriophage was determined by the presence of transparent spots (plaques), clearly visible against the matte background of bacterial growth. Isolated plaques were selected, suspended in sterile saline, then chloroform was added to the suspension, taken in a volume of 0.5-0.6 ml. The resulting suspension was incubated at room temperature for 20-30 minutes, then the incubated suspension was centrifuged at 4000-5000 rpm for 20-30 minutes and the supernatant was taken into a sterile tube.

Confirmation of the taxonomy of isolated phages was performed by genus specific PCRs. Following primers were designed for it (Table 1). Moreover we tested a presence of known integrase genes as described before [11]. The phage samples for the PCRs were consistently filtered via the 0.22 ^m PES syringe filter, treated with the DNAse I and the resulting phage DNA was isolated using the spin-column K-Sorb kit (Syn-tol, Russia). The PCR was performed using standard recombinant Taq-polymerase chemistry (Thermo Fisher Scientific, USA) on the CFX96 Real-time amplifier (Bio-Rad, USA).

Table 1

Oligonucleotide primers for phage identification__

Primer name Oligonucleotide sequence, 5'-3' Size of the amplicon, bp Annealing temperature, °C MgCl concentration, mM Target genus

KV_caps_fw gta cgc tga cca att cca ag 276 59 l,8 Kayvirus

KV_caps_rv tca gat act ggt gct act cc

RV_caps_fw gat aat cac cgt aag cac gt 580 5V l,8 Rosenblumvi-rus

RV_caps_rv cgt aat tat cca cgt atg gc

Results. In the course of the work, 110 staphylococcal isolates with lecithinase activity were isolated and characterized. Of these, 106 isolates were identified by PCR as S. aureus and 9 isolates exhibited lysog-enic properties. All isolates showed resistance to at least one antibiotic.

A conventional plaque assay showed no bacteriophages within the cultures. However, after mitomycin C induction 7 cultures were phage-positive. The results are shown in Table 2.

Table 2

Results of the efficacy of isolation of phages from cultures of Staphylococcus aureus_

Name of the biofilm producing

S. aureus isolate

OD595 of the biofilm, M±SD

Result after the conventional phage isolation

Result after phage isolation with mitomycin C

Phage name

Plaque morphology

Plaques figure

3А27

0.053±0.007

Not isolated

Isolated

Astl

01-1.5 mm with Halo

9зев!4

0.803±0.09l

Not isolated

Isolated

Ast2

01-1.5 mm with Halo

Name of the biofilm producing S. aureus isolate ODS95 of the biofilm, M±SD Result after the conventional phage isolation Result after phage isolation with mitomycin C Phage name Plaque morphology Plaques figure

73eBl4 0.408±0.053 Not isolated Isolated Ast3 00.5-1 mm with Halo Л

43eBl4 0.976±0.101 Not isolated Isolated Ast4 01-2 mm without Halo •C;;

2ageH 0.047±0.006 Not isolated Isolated Ast5 01-1.5 mm without Halo ii-;

125 0.105±0.011 Not isolated Isolated Ast6 01-1.5 mm with Halo til

Name of the biofilm producing S. aureus isolate ODS95 of the biofilm, M±SD Result after the conventional phage isolation Result after phage isolation with mitomycin C Phage name Plaque morphology Plaques figure

147 0.053±0.008 Not isolated Isolated Ast7 01-1.5 mm without Halo

Results from the Table 3 demonstrate different morphology of plaques of bacteriophage isolates isolated as a result of the addition of mitomycin C. However results of the PCR tests showed that all isolated bacteriophages belong to the Kayvirus genus. Moreover, no phage genome associated integrases typical for S. aureus were detected.

Table 3

Taxonomy identification of isolated bacteriophages

Phage name Genera o f lytic S. aureus phages S. aureus integrase genes [20]

Kayvirus Rosenblumvirus Saiint Sa2int Sa3int Sa4int Sa5int Sa6int Sa7int

Asti + - - - - - - - -

Ast2 + - - - - - - - -

Ast3 + - - - - - - - -

Ast4 + - - - - - - - -

Ast5 + - - - - - - - -

Ast6 + - - - - - - - -

Ast7 + - - - - - - - -

Conclusions. Results of the present work demonstrate the chronically S. aureus colonized tonsils as a new source for isolation of bacteriophages against these staphylococci. In particularly the cultures of the S. aureus themselves can be considered as a source of lytic phages. This novel finding correlate good with recent results of works of Glowacka-Rutkowska A. et al. [9, 10].

The fact of mitomycin C induction of the Kayvirus bacteriophages, that were previously known only as lytic, bring new direction of both development of new phage isolation methods and optimization of phage therapy. According to the NCBI database currently at least 56 representatives of this genus have annotated genome (https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=1857843). Since the first publication of the type species phage K genome (S. O'Flaherty et al., 2004) a number of studies of the Kayvirus phages demonstrate strongly the absence of integrases or other factors able to provide the temperate life cycle [17, 18]. However, the coexistence of these bacteriophages and clinical isolates indicates a possibility of the pseudolysogenic life cycle for the representative of the genus Kayvirus and matches to the recent hypothesis [10]. Further, we are planning to present complete genome sequences of the isolated Kayviruses.

In general the pseudolysogeny is not a contraindication for therapeutic application of bacteriophages but under this condition efficacy of phage therapy can be decreased. Thus further evaluation of the factors provoke the pseudolysogeny by isolated phages as well as evaluation of known Kayvirus phages and S. aureus coexistence is required in order to develop clinical recommendations for optimal phage therapy.

Acknowledgements. The research was carried out in a frame of the state assignment of Ministry of Health of Russian Federation. The research was supported by gratuitous agreements of scientific cooperation.

References

1. Abedon, S. T. Phage therapy: eco-physiological pharmacology. Scientifica, 2014, vol. 2014, article ID 581639. doi: 10.1155/2014/581639.

2. Abedon, S. T. Bacteriophage exploitation of bacterial biofilms: Phage preference for less mature targets? FEMS microbiology letters, 2016, vol. 363, no. 3, PII fnv246. doi: 10.1093/femsle/fnv246.

3. Aleshkin A. V., Ershova O. N., Volozhantsev N. V. , Svetoch E. A., Popova A. V., Rubalskii E. O., Borzilov A. I., Aleshkin V. A. , Afanas'ev S. S., Karaulov A. V., Galimzyanov K. M., Rubalsky O. V., Bochkareva S. S.. Phage-biotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage, 2016, vol. 6, no. 4, e1251379. doi: 10.1080/21597081.2016.1251379.

4. Bai J., Kim Y. T., Ryu S., Lee J. H. Biocontrol and rapid detection of food-borne pathogens using bacteriophages and endolysins. Frontiers in microbiology, 2016, vol. 7, article 474. doi: 10.3389/fmicb.2016.00474.

5. Billard-Pomares T., Fouteau S., Jacquet M. E., Roche D., Barbe V., Castellanos M., Bouet J. Y., Cruveiller S., Medigue C., Blanco J., Clermont O., Denamur E., Branger C. Characterization of a P1-like bacteriophage carrying an SHV-2 extended-spectrum ß-lactamase from an Escherichia coli strain. Antimicrobial Agents Chemotherapy, 2014, vol. 58 (11), p. 6550-6557. doi: 10.1128/AAC.03183-14.

6. Bochkareva S. S., Aleshkin A. V., Ershova O. N., Novikova L. I., Karaulov A. V., Kiseleva I. A., Zul'karneev E. R., Rubal'skiy E. O., Zeigarnik M. V. Anti-phage antibody response in phage therapy against healthcare-associated infections (HAIs). Infectious diseases, 2017, vol. 15, no. 1, pp. 35-40. doi: 10.20953/1729-9225-20171-35-40.

7. Bondy-Denomy J., Qian J., Westra E. R., Buckling A., Guttman D. S., Davidson A. R., Maxwell K. L. Prophages mediate defense against phage infection through diverse mechanisms. The ISME journal, 2016, vol. 10, no. 12, pp. 2854-2866. doi: 10.1038/ismej.2016.79.

8. Cavalcanti V. P., de Camargo L. A., Moura F. S., de Melo Fernandes E. J. Staphylococcus aureus in tonsils of patients with recurrent tonsillitis: prevalence, susceptibility profile, and genotypic characterization. Brazilian Journal of Infectious Diseases, 2019, vol. 23, no. 1, pp. 8-14. doi: 10.1016/j.bjid.2018.12.003.

9. Glowacka-Rutkowska A., Gozdek A., Empel J., Gawor J., Zuchniewicz K., Kozinska A., D^bski J., Gromadka R., Lobocka M. The ability of lytic staphylococcal Podovirus vB_SauP_phiAGO1.3 to coexist in equilibrium with its host facilitates the selection of host mutants of attenuated virulence but does not preclude the phage antistaphylococcal activity in a nematode infection model. Frontiers in microbiology, 2019, vol. 9, article 3227. doi: 10.3389/fmicb.2018.03227.

10. Glowacka-Rutkowska A, Ulatowska M, Empel J, Kowalczyk M, Boreczek J, Lobocka M. A Kayvirus distant homolog of staphylococcal virulence determinants and VISA biomarker is a phage lytic enzyme. Viruses, 2020, vol. 12, no. 3, p. 292. doi: 10.3390/v12030292.

11. Goerke C., Pantucek R., Holtfreter S., Schulte B., Zink M., Grumann D., Bröker B. M., Doskar J., Wolz C. Diversity of prophages in dominant Staphylococcus aureus clonal lineages. Journal of bacteriology, 2009, vol. 191, no. 11, pp. 3462-3468. doi: 10.1128/JB.01804-08.

12. Krahn T., Wibberg D., Maus I., Winkler A., Bontron S., Sczyrba A., Nordmann P., Pühler A., Poirel L., Schlüter A. Intraspecies transfer of the chromosomally encoded Acinetobacter baumannii blaNDM-1 carbapenemase gene. Antimicrobial Agents Chemotherapy, 2016, vol. 60 (5), pp. 3032-3040. doi: 10.1128/AAC.00124-16.

13. Kutter E., Sulakvelidze A. Bacteriophages: biology and applications. Boca Raton, London, New York, Washington: CRC Press, 2005, 510 p.

14. Levin-Reisman I., Ronin I., Gefen O., Braniss I., Shoresh N., Balaban N. Q. Antibiotic tolerance facilitates the evolution of resistance. Science (New York, N.Y.), 2017, vol. 355, no. 6327, pp. 826-830. doi: 10.1126/science.aaj2191.

15. McCarthy A. J., Witney A. A., Lindsay J. A. Staphylococcus aureus temperate bacteriophage: carriage and horizontal gene transfer is lineage associated. Frontiers in cellular and infection microbiology, 2012, vol. 2, article 6. doi: 10.3389/fcimb.2012.00006.

16. Miller-Ensminger T., Garretto A., Brenner J., Thomas-White K., Zambom A., Wolfe A. J., Putonti C. Bacterio-phages of the urinary microbiome. Journal Bacteriological, 2018, vol. 200, no. 7, e00738-17. doi: 10.1128/JB.00738-17.

17. Oduor J. M. O., Kiljunen S., Kadija E., Mureithi M. W., Nyachieo A., Skurnik M. Genomic characterization of four novel Staphylococcus myoviruses. Archives of virology, 2019 vol. 164, no. 8, pp. 2171-2173. doi: 10.1007/s00705-019-04267-0.

18. O'Flaherty S., Coffey A., Edwards R., Meaney W., Fitzgerald G. F., Ross R. P. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. Journal of bacteriology, 2004, vol. 186, no. 9, pp. 2862-2871. doi:10.1128/jb.186.9.2862-2871.2004.

19. Sekizuka T., Yamamoto A., Komiya T., Kenri T., Takeuchi F., Shibayama K., Takahashi M., Kuroda M., Iwaki M. Corynebacterium ulcerans 0102 carries the gene encoding diphtheria toxin on a prophage different from the C. diphthe-riae NCTC 13129 prophage. BMC Microbiology, 2012, vol. 12, Article number: 72. doi: 10.1186/1471-2180-12-72.

20. Stepanovic S., Vukovic D. N., Dakic I. R., Savic B., Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. Journal of microbiological methods, 2000, vol. 40, no. 2, pp. 175-179. doi: 10.1016/s0167-7012(00)00122-6.

21. Stewart P. S. Antimicrobial tolerance in biofilms. Microbiology spectrum, 2015, vol. 3, no. 3. doi: 10.1128/microbiolspec.MB-0010-2014.

22. Umminger J., Krueger H., Beckmann E., Kaufeld T., Fleissner F., Haverich A., Shrestha M., Martens A. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery, 2016, vol. 50, no. 4, pp. 660-667. doi: 10.1093/ejcts/ezw150.

14.01.08 - Педиатрия (медицинские науки)

УДК 616.24-001

DOI 10.17021/2020.15.4.15.23

© И.А. Аверина, Д.Ф. Сергиенко, 2020

АНАЛИЗ УРОВНЯ ВИТАМИНА D У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ РЕСПИРАТОРНОЙ ПАТОЛОГИЕЙ И У ЗДОРОВЫХ ДЕТЕЙ В АСТРАХАНСКОЙ ОБЛАСТИ

Аверина Ирина Анатольевна, аспирант кафедры факультетской педиатрии, ФГБОУ ВО «Астраханский государственный медицинский университет» Минздрава России, Россия, 414000, г. Астрахань, ул. Бакинская, д. 121, тел.: 8-908-610-67-40, e-mail: [email protected].

Сергиенко Диана Фикретовна, доктор медицинских наук, профессор кафедры факультетской педиатрии, ФГБОУ ВО «Астраханский государственный медицинский университет» Минздрава России, Россия, 414000, г. Астрахань, ул. Бакинская, д. 121, тел.: 8-927-280-40-21, e-mail: [email protected].

Изучен статус витамина D у когорты пациентов с хроническими заболеваниями легких, конкретизированы показатели сывороточного кальцидиола у группы контроля, состоящей из условно здоровых детей Астраханской области. Выявлена закономерность значений сывороточного кальцидиола, обусловленная этиологией возникновения хронических заболеваний легких, определены показатели уровня витамина D в сыворотке крови у детей контрольной группы. Проанализирована ось значений уровня витамина D в зависимости от возрастного аспекта и тендерного фактора у пациентов с хроническими заболеваниями легких и в группе контроля.

Ключевые слова: хронические заболевания легких, хронический бронхит, муковисцидоз, иммунодефици-ты, витамин D, дети.

ANALYSIS OF VITAMIN D LEVELS IN PATIENTS WITH CHRONIC RESPIRATORY PATHOLOGY AND HEALTHY CHILDREN IN ASTRAKHAN REGION

Averina Irina A., post graduate student, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: 8-908-610-67-40, e-mail: [email protected].

Sergienko Diana F., Dr. Sci. (Med.), Professor of Department, Astrakhan State Medical University, 121 Bakinskaya St., Astrakhan, 414000, Russia, tel.: 8-927-280-40-21, e-mail: [email protected].

Vitamin D status was studied in a cohort of patients with chronic lung diseases, serum calcidiol indicators were specified in a control group consisting of conditionally healthy children of the Astrakhan region. The regularity of serum calcidiol values is revealed due to the aetiology of chronic lung diseases, the serum vitamin D levels in the children of the control group are determined. The axis of vitamin D levels according to age aspect and gender factor in patients with chronic lung diseases and the control group was analyzed.

Key words: chronic lung diseases, chronic bronchitis, cystic fibrosis, immunodeficiencies, vitamin D, children.

Введение. Хронические заболевания легких (ХЗЛ), представленные большим разнообразием нозологических форм, являются наиболее сложным разделом детской пульмонологии. Хроническое поражение органов дыхания ассоциировано с постоянным интоксикационным синдромом, гипоксией, изменениями в системе иммунитета, что ведет к ранней инвалидизации больных, необходимости